Lataa...
Expression of a dominant T-cell receptor can reduce toxicity and enhance tumor protection of allogeneic T-cell therapy
Due to the lack of specificity for tumor antigens, allogeneic T-cell therapy is associated with graft-versus-host disease. Enhancing the anti-tumor specificity while reducing the graft-versus-host disease risk of allogeneic T cells has remained a research focus. In this study, we demonstrate that th...
Tallennettuna:
| Julkaisussa: | Haematologica |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Ferrata Storti Foundation
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5004405/ https://ncbi.nlm.nih.gov/pubmed/26802053 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2015.132712 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|